Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Zinc complexes formed by 2,2′-bipyridine and 1,10-phenanthroline moieties combined with 2-azanorbornane: modular chiral catalysts for aldol reactions

Elżbieta Wojaczyńska *a, Jacek Skarżewski a, Łukasz Sidorowicz a, Robert Wieczorek b and Jacek Wojaczyński b
aDepartament of Organic Chemistry, Faculty of Chemistry, Wrocław University of Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland. E-mail: elzbieta.wojaczynska@pwr.edu.pl; Fax: +48 713202427; Tel: +48 713202410
bDepartment of Chemistry, University of Wrocław, 14 F. Joliot-Curie St., 50-383 Wrocław, Poland

Received (in Victoria, Australia) 19th July 2016 , Accepted 30th September 2016

First published on 30th September 2016


Chiral scaffolds of 2-azabicyclo[2.2.1]heptane and 2-azabicyclo[3.2.1]octane were used for the construction of new modular catalysts containing complexing moieties pyridine, 2,2′-bipyridine and 1,10-phenanthroline appended by an imine linkage. The coordination abilities of the new ligands towards Zn(II) were investigated using NMR and UV spectroscopy. The plausible structures of the [ZnL2]2+ and [ZnLXn](2−n)+ complexes formed were established by comparison of the experimental and DFT-calculated NMR spectra. The catalytic application of the [ZnLXn](2−n)+-type complexes in the asymmetric aldol reaction of ketones with aromatic aldehydes produced an excess of the respective syn-aldols in up to >98% ee.


Introduction

A quest for new, effective tools for asymmetric synthesis led to the concept of modular chiral ligands and catalysts – assemblies of individual fragments performing diverse and complementary roles.1 Each of these parts can be appropriately modified to fulfill the exact requirements of the catalyzed reaction. In this approach, one combines various functionalities, already known for their basicity and stereodifferentiating properties, with the achiral ligands binding metal ions serving as a Lewis acid center. Among the possible elements of these modular catalysts, N,N-bidentate ligands, with appropriately oriented nitrogen atoms that enable the formation of strong complexes are particularly promising. The versatility of aromatic diamines, 2,2′-bipyridine and 1,10-phenanthroline, prompted various research groups to use these motifs for the construction of chiral catalysts for stereoselective processes.2 As a recent example, a tridentate ligand containing phenanthroline attached to an axially chiral binaphthyl moiety was found to be effective in enantioselective addition of diethylzinc to aromatic aldehydes (with up to 95% ee).3

In this contribution, we describe the use of two bicyclic chiral scaffolds, 2-azabicyclo[2.2.1]heptane (2-azanorbornane) and 2-azabicyclo[3.2.1]octane (bridged azepane), for the construction of bifunctional catalysts containing the metal-complexing moieties 1,10-phenanthroline and 2,2′-bipyridine (Fig. 1). We propose a simple method of module assembling by an imine linkage which introduces a favorably located additional donor atom. Changing the ring size of the chiral scaffold, the configuration of stereocenters and the heteroaromatic amine should allow for fine tuning of the catalytic properties and optimization of asymmetric induction.


image file: c6nj02251k-f1.tif
Fig. 1 Modular chiral catalysts used in this study.

2-Azanorbornane, bearing a stable bicyclic skeleton with an intrinsic chirality, has been recognized as a versatile scaffold for asymmetric synthesis.4 This system is readily available via the stereoselective aza-Diels–Alder reaction of chiral imines and cyclopentadiene. Its preparation in both enantiomeric forms in a gram or even kilogram scale has been described.5,6 The derivatives of 2-azabicyclo[2.2.1]heptane after various modifications of the basic structure lead to a number of (N,O), (N,N), (N,P), and (N,S)-donating ligands, which have already been applied in various enantioselective transformations.4,7 Thus, both alcohol epimers (1 and 2), differing in the configuration on the 3-C stereocenter can be prepared from the separated isomeric cycloadducts formed in one aza-Diels–Alder reaction. In the course of our earlier studies, we have observed that upon attempted nucleophilic substitution of a hydroxyl group in alcohol 2 a stereoselective ring expansion takes place, yielding 2-azabicyclo[3.2.1]octane.8 In this way, amines based on the bridged piperidine (3/4) or azepane (5/6, Fig. 2) can be prepared and applied to the construction of bifunctional catalysts bearing a stereodifferentiating bicyclic skeleton with a tertiary amine function.


image file: c6nj02251k-f2.tif
Fig. 2 Chiral bicyclic precursors of the modular ligands used in this study.

Among the catalytic reactions leading to the formation of new C–C bonds, the aldol reaction plays an important role. In its asymmetric variant, two stereocenters can be generated with high stereoselectivity.9 Nature exploits this reaction catalyzed by aldolases for biosynthesis. While type I aldolases operate via an enamine mechanism, type II enzymes use enolate-type activation with a metal cofactor (typically Zn2+ ion). Accordingly, both organocatalysts and various metal complexes (in particular, Zn(II)-based catalysts) were effective in diastereo- and enantioselective processes.9,10 In this contribution, we describe our studies on the application of zinc complexes of phenanthroline- and bipyridine-derived chiral hybrid catalysts in the stereoselective aldol reaction.

Experimental section

Optical rotations were measured using an Optical Activity Ltd Model AA-5 automatic polarimeter; [α]D values are given in 10−1 deg cm2 g−1. IR spectra were recorded on a Perkin Elmer 1600 FTIR spectrophotometer. 1H NMR and 13C NMR spectra were measured on a Bruker Avance (1H, 500 MHz) spectrometer using the solvent residual peak (chloroform-d, δ(1H) = 7.28 ppm, δ(13C) = 77.0 ppm) as a reference. High resolution mass spectra were recorded using a micrOTOF-Q and a WATERS LCT Premier XE instrument utilizing the electrospray ionization mode. Chromatographic separations were performed on silica gel 60 (70–230 mesh). Thin layer chromatography was carried out using silica gel 60 precoated plates. HPLC analyses were performed on Chiralcel OD-H or Chiralpak AD-H chiral columns (flow rate of 1.0 mL min−1).

Preparation of compounds

Alcohols 1 and 2 were prepared according to a literature procedure.11 Their Swern oxidation led to the corresponding aldehydes.12 Amine 3 was synthesized from aldehyde 7 in a two-step procedure as recently described.13

Amine 4 was prepared in an analogous manner from the respective endo aldehyde obtained from alcohol endo-2. Amines based on a bridged azepane skeleton 5 and 6 were obtained from alcohols 1 and 2, respectively, as described previously.8

(1S,3S,4R,1′S)-4. Light yellow oil (0.38 g, 70%). [α]20D = −23.5 (1.15, CH2Cl2). IR (film): νmax/cm−1 3024, 2967, 2870, 1603, 1492, 1452, 1304, 1162, 1027, 766, 701. 1H NMR (500 MHz, CDCl3, Me4Si) δ = 1.04–1.09 (2H, m), 1.27–1.39 (2H, m), 1.30 (3H, d, J = 6.5 Hz), 1.55–1.60 (2H, m), 1.62–1.69 (1H, m), 1.85–1.89 (1H, m), 2.10 (1H, dd, J1 = 9.0 Hz, J2 = 2.5 Hz), 2.28 (1H, d, J = 4.0 Hz), 2.58 and 2.72 (2H, ABX, JAB = 13.0 Hz, JAX = 9.0 Hz, JBX = 2.5 Hz), 2.90 (1H, s), 3.59 (1H, q, J = 6.5 Hz), 7.20–7.34 (5H, m). 13C NMR (125 MHz, CDCl3, Me4Si) δ = 22.7, 25.2, 29.1, 35.2, 40.7, 48.7, 58.9, 60.3, 70.6, 126.6, 127.4, 128.3, 146.3. HRMS (ESI-TOF): m/z calculated for (C15H23N2)+ ([M + H]+) 231.1861; found 231.1865.
(1S,4R,5R,1′S)-6. Yellow oil (0.40 g, 48%). [α]20D = −19.8 (0.61, CH2Cl2). IR (film): νmax/cm−1 3024, 2935, 1601, 1492, 1452, 1370, 1212, 1112, 1028, 766, 701. 1H NMR (500 MHz, CDCl3, Me4Si) δ = 1.03–1.07 (1H, m), 1.14–1.21 (1H, m), 1.25 (3H, d, J = 6.6 Hz), 1.30–1.36 (2H, m), 1.63–1.79 (6H, m), 1.90 (1H, d, J = 11.6 Hz), 2.13–2.15 (1H, m), 2.43 (1H, dd, J1 = 11.6 Hz, J2 = 3.8 Hz), 2.73–2.78 (1H, m), 2.96–2.98 (1H, m), 3.36 (1H, q, J = 6.6 Hz), 7.21–7.24 (1H, m), 7.28–7.36 (4H, m). 13C NMR (125 MHz, CDCl3, Me4Si) δ = 21.0, 22.1, 27.9, 33.0, 41.6, 50.6, 51.1, 57.6, 62.0, 126.7, 127.6, 128.3, 146.0. HRMS (ESI-TOF): m/z calculated for (C15H23N2)+ ([M + H]+) 231.1861; found 231.1870.
Synthesis of imines. Amine 3 (0.12 g, 0.5 mmol) and 2-pyridinecarboxaldehyde (0.054 g, 0.5 mmol) were dissolved in 8 mL of dichloromethane and stirred overnight at room temperature over anhydrous Na2SO4. The solution was filtered, and solvent was removed under a reduced pressure. Washing with an n-hexane/diethyl ether mixture (1[thin space (1/6-em)]:[thin space (1/6-em)]1) yielded compound 9 as a yellow solid.

A similar procedure was applied to the synthesis of derivatives 10 and 11 using 2,2′-bipyridyl-6-carboxaldehyde and 1,10-phenanthroline-2-carboxaldehyde, respectively. These aldehydes were prepared from their parent compounds (2,2′-bipyridyl and 1,10-phenanthroline) using the adopted literature procedure14 leading to primary alcohols which were oxidized under Swern conditions. 1,10-Phenanthroline-2-carboxaldehyde was also reacted with amines 4, 5, and 6 to yield ligands 12, 13, and 14, respectively. All imines were found to be unstable on silica and attempts of chromatographic purification were unsuccessful.

(1S,3R,4R,1′S)-9. Yellow oil (0.16 g, 95%). [α]20D = −38.4 (0.56, CH2Cl2). IR (KBr): νmax/cm−1 3061, 3026, 2969, 2869, 1647, 1587, 1567, 1468, 1453, 1305, 1165, 774, 754, 701. 1H NMR: δH (500 MHz; CDCl3; Me4Si) 1.29–1.44 (3H, m), 1.40 (3H, d, 6.5 Hz), 1.61–1.68 (1H, m), 1.83–1.89 (1H, m), 1.99–2.04 (1H, m), 2.30 (1H, bd, J = 6.5 Hz), 2.32 (1H, s), 2.54 (1H, dd, J1 = 11.3 Hz, J2 = 2.6 Hz), 3.04 (1H, t, J = 10.2 Hz), 3.54 (1H, q, J = 6.5 Hz), 3.67 (1H, s), 7.25–7.30 (2H, m), 7.33 (t, 2H, J = 7.3 Hz), 7.41 (2H, bd, J = 7.0 Hz), 7.67 (1H, td, J1 = 7.8 Hz, J2 = 1.7 Hz), 7.75 (1H, s), 7.84 (1H, d, J = 7.9 Hz), 8.60 (1H, ddd, J1 = 4.8 Hz, J2 = 1.7 Hz, J3 = 0.9 Hz). 13C NMR: δC (125 MHz; CDCl3; Me4Si) 22.6 (two overlapping signals), 28.9, 35.0, 39.7, 59.0, 61.1, 66.3, 69.7, 121.3, 124.4, 127.4, 128.2, 128.4, 136.4, 145.2, 146.2, 149.3, 161.9. HRMS (ESI-TOF): m/z calculated for (C21H26N3)+ ([M + H]+) 320.2127; found 320.2136.
(1S,3R,4R,1′S)-10. Yellow oil (0.19 g, 92%). [α]20D = −30.2 (0.63, CH2Cl2). IR (KBr): νmax/cm−1 3435, 2968, 1868, 1645, 1581, 1563, 1454, 1430, 1304, 1165, 1076, 990, 779, 701. 1H NMR: δH (500 MHz; CDCl3; Me4Si) 1.29–1.45 (3H, m), 1.38 (3H, d, J = 6.0 Hz), 1.58–1.67 (1H, m), 1.89 (1H, d, J = 10.0 Hz), 2.02–2.06 (1H, m), 2.31–2.33 (2H, m), 2.63 (1H, dd, J1 = 11.4 Hz, J2 = 2.0 Hz), 3.07 (1H, t, J = 10.4 Hz), 3.56 (1H, q, J = 6.3 Hz), 3.68 (1H, s), 7.28–7.38 (5H, m), 7.43 (2H, d, J = 7.2 Hz), 7.80–7.92 (4H, m), 8.38 (1H, dd, J1 = 7.8 Hz, J2 = 1.0 Hz), 8.46 (1H, dt, J1 = 8.0 Hz, J2 = 1.0 Hz), 8.69 (1H, dd, J1 = 4.8 Hz, J2 = 1.8 Hz) ppm. 13C NMR: δC (125 MHz; CDCl3; Me4Si) 22.6 (2 signals), 29.0, 35.0, 39.7, 59.0, 61.1, 66.3, 69.7, 120.9, 121.1, 121.8, 123.8, 127.4; 128.3, 128.4, 136.9, 137.2, 146.3, 149.2, 154.4, 155.6, 155.9, 162.5. HRMS (ESI-TOF): m/z calculated for (C26H29N4)+ ([M + H]+) 397.2392; found 397.2371.
(1S,3R,4R,1′S)-11. Yellow solid (0.19 g, 90%). [α]20D = −35.6 (0.45, CH2Cl2). M.p. 82–83 °C. UV-vis: λmax (CH2Cl2, log[thin space (1/6-em)]ε) = 233 (4.64), 277 (4.48), 309 sh, 330 (3.55), 346 (3.19). IR (KBr): νmax/cm−1 3420, 3028, 2967, 2868, 1709, 1644, 1554, 1491, 1450, 1304, 1164, 1081, 1026, 856, 701, 625. 1H NMR: δH (500 MHz; CDCl3; Me4Si) 1.27–1.48 (3H, m), 1.42 (3H, d, J = 6.6 Hz), 1.62–1.67 (1H, m), 1.91–1.92 (1H, m), 2.02–2.07 (1H, m), 2.31–2.32 (1H, m), 2.43 (1H, dd, J1 = 10.0 Hz, J2 = 4.0 Hz), 2.77 (1H, ddd, J1 = 12.0 Hz, J2 = 4.0 Hz, J3 = 1.6 Hz), 3.11 (1H, t, J = 11.0 Hz), 3.58 (1H, q, J = 6.4 Hz), 3.69 (1H, bs), 7.30 (1H, t, J = 7.4 Hz), 7.35 (2H, t, J = 7.3 Hz), 7.44 (2H, d, J = 7.2 Hz), 7.66 (1H, dd, J1 = 8.0 Hz, J2 = 4.4 Hz), 7.78 and 7.81 (2H, ABq, J = 8.8 Hz), 8.21 and 8.27 (2H, ABq, J = 8.4 Hz), 8.25 (1H, dd, J1 = 8.0 Hz, J2 = 1.8 Hz), 8.47 (1H, s, NH), 9.23 (1H, dd, J1 = 4.4 Hz, J2 = 1.8 Hz). 13C NMR: δC (125 MHz; CDCl3; Me4Si) 22.7, 22.9, 28.9, 34.9, 39.3, 59.1, 61.2, 66.0, 69.4, 120.4, 123.1, 126.4, 127.2, 127.5, 128.27, 128.30, 128.9, 129.3, 136.2, 136.4, 145.6, 146.1, 146.3, 150.6, 155.0, 163.0. HRMS (ESI-TOF): m/z calculated for (C28H28N4Na)+ ([M + Na]+) 443.2212; found 443.2213.
(1S,3R,4R,1′S)-12. Yellow oil (0.16 g, 71%). [α]20D = +17.8 (0.62, CH2Cl2). IR (KBr): νmax/cm−1 3435, 2965, 2868, 1644, 1618, 1491, 1451, 1304, 1161, 856, 702. 1H NMR: δH (500 MHz; CDCl3; Me4Si) 1.04–1.13 (2H, m), 1.24–1.31 (1H, m), 1.44 (3H, d, J = 6.5 Hz), 1.54–1.58 (1H, m), 1.80–1.84 (1H, m), 1.90–1.97 (1H, m), 2.37 (1H, d, J = 4.0 Hz), 2.59 (1H, dd, J1 = 10.0 Hz, J2 = 3.5 Hz), 2.97 (1H, bs), 3.62 (1H, ddd, J1 = 12.0 Hz, J2 = 10.0 Hz, J3 = 1.5 Hz), 3.67 (1H, q, J = 6.5 Hz), 3.93 (1H, ddd, J1 = 12.0 Hz, J2 = 3.5 Hz, J3 = 1.5 Hz), 7.22 (1H, t, J = 7.5 Hz), 7.30 (2H, t, J = 7.5 Hz), 7.37 (2H, d, J = 7.4 Hz), 7.66 (1H, dd, J1 = 8.0 Hz, J2 = 4.3 Hz), 7.83 (2H, s), 8.30 and 8.44 (2H, ABq, J = 8.5 Hz), 8.27 (1H, dd, J1 = 8.0 Hz, J2 = 2.0 Hz), 8.95 (1H, s, NH), 9.24 (1H, dd, J1 = 4.3 Hz, J2 = 2.0 Hz). 13C NMR: δC (125 MHz; CDCl3; Me4Si) 22.9, 25.3, 28.7, 34.9, 40.5, 59.3, 60.4, 67.8, 68.7, 120.4, 123.2, 126.5, 126.6, 127.38, 127.43, 128.3, 128.9, 129.4, 136.2, 136.6, 145.8, 146.2, 146.3, 150.7, 155.0, 163.7. HRMS (ESI-TOF): m/z calculated for (C28H29N4)+ ([M + H]+) 421.2392; found 421.2381.
(1S,4S,5R,1′S)-13. Yellow solid (0.14 g, 69%). [α]20D = +100.0 (0.57, CH2Cl2), m.p. 52–54 °C. IR (KBr): νmax/cm−1 3443, 3059, 3026, 2932, 2863, 1711, 1641, 1491, 1451, 1370, 1134, 1100, 953, 857, 771, 702. 1H NMR: δH (500 MHz; CDCl3; Me4Si) 1.13–1.17 (1H, m), 1.34 (3H, d, J = 6.5 Hz), 1.58–1.63 (1H, m), 1.76–1.82 (1H, m), 1.90–1.96 (1H, m), 2.25–2.28 (1H, m), 2.46 (1H, d, J = 10.4 Hz), 2.72 (1H, dd, J1 = 12.7 Hz, J2 = 4.0 Hz), 2.97 (1H, d, J = 12.6 Hz), 3.28 (1H, t, J = 5.0 Hz), 3.45 (1H, bs), 3.64 (1H, q, J = 6.5 Hz), 7.20 (1H, t, J = 7.2 Hz), 7.28 (2H, t, J = 7.4 Hz), 7.39 (2H, d, J = 7.3 Hz), 7.67 (1H, dd, J1 = 8.0 Hz, J2 = 4.3 Hz), 7.85 and 7.87 (2H, ABq, J = 8.8 Hz), 8.35 and 8.61 (2H, ABq, J = 8.3 Hz), 8.29 (1H, dd, J1 = 8.1 Hz, J2 = 1.7 Hz), 8.95 (1H, s, NH), 9.25 (1H, dd, J1 = 4.3 Hz, J2 = 1.7 Hz). 13C NMR: δC (125 MHz; CDCl3; Me4Si) 22.1, 23.2, 27.9, 32.7, 41.6, 49.7, 57.2, 62.3, 70.3, 120.8, 123.1, 126.5, 127.2; 127.5, 127.7, 128.2, 128.9, 129.3, 136.2, 136.6, 145.7, 146.2, 146.4, 150.6, 155.5, 161.2. HRMS (ESI-TOF): m/z calculated for (C28H28N4Na)+ ([M + Na]+) 443.2212; found 443.2213.
(1S,4R,5R,1′S)-14. Yellow solidifying oil (0.20 g, 95%). [α]20D = +40.7 (0.36, CH2Cl2). IR (KBr): νmax/cm−1 3430, 2930, 2860, 1641, 1617, 1554, 1490, 1451, 1370, 1113, 856, 701. 1H NMR: δH (500 MHz; CDCl3; Me4Si) 1.25–1.29 (4H, m), 1.59–1.62 (1H, m), 1.78–1.85 (2H, m), 2.27–2.28 (1H, m), 2.61 (1H, d, J = 11.2 Hz), 2.59–2.72 (2H, m), 3.35 (1H, bs), 3.63–3.68 (2H, m), 7.20 (1H, t, J = 7.2 Hz), 7.30 (2H, t, J = 7.4 Hz), 7.42 (2H, bd, J = 7.4 Hz), 7.66 (1H, dd, J1 = 8.0 Hz, J2 = 4.3 Hz), 7.83 and 7.85 (2H, ABq, J = 8.8 Hz), 8.35 and 8.54 (2H, ABq, J = 8.3 Hz), 8.28 (1H, dd, J1 = 8.0 Hz, J2 = 1.8 Hz), 8.85 (1H, s, NH), 9.23 (1H, dd, J1 = 4.4 Hz, J2 = 1.7 Hz). 13C NMR: δC (125 MHz; CDCl3; Me4Si) 22.1, 23.2, 27.9, 32.7, 41.6, 49.7, 57.2, 62.3, 70.3, 120.7, 123.1, 126.5, 127.2; 127.6, 128.3, 128.6, 128.9, 129.3, 136.2, 136.5, 145.7, 146.2, 150.5, 155.3, 161.5. HRMS (ESI-TOF): m/z calculated for (C28H28N4Na)+ ([M + Na]+) 443.2212; found 443.2216.

Typical procedure for aldol reactions15

A chiral ligand (9–14, 0.05 mmol) and 0.05 mmol of zinc(II) acetate were dissolved in 2 mL of a chloroform–cyclohexanone (1[thin space (1/6-em)]:[thin space (1/6-em)]1) mixture and stirred for 10 minutes at room temperature. The appropriate aldehyde (0.5 mmol) was then added and the resulting solution was stirred for 6 days at room temperature. The reaction mixture was purified via column chromatography on silica (n-hexane/ethyl acetate 3[thin space (1/6-em)]:[thin space (1/6-em)]1). Diastereomeric excess and enantiomeric excess were determined using chiral HPLC analysis. For the 2-[hydroxy-(4-nitrophenyl)methyl]cyclohexanone product, a Chiralpak AD-H column was used (n-hexane/isopropanol 90/10, 1.0 mL min−1, 254 nm): tR(syn) 17.1 min, 20.4 min, tR(anti) 22.7 min, 30.8 min.

In modified variants of the procedure zinc acetate was replaced with zinc triflate; in certain cases 0.05 mmol acetic acid was added together with zinc(II) salt. The chosen reactions were conducted at 273 K.

Theoretical calculations

Molecular orbital studies on ligands 10 and 11 and their Zn(II) complexes were performed at the DFT level of theory using the Gaussian 09 suite of programs16 with the M06 hybrid functional17 and 6-311G(d,p) basis set. The PCM (IEFPCM) implicit model18 of the methanol environment was embodied to the DFT calculations. The proton nuclear magnetic resonance (NMR) shifts of the investigated complexes in solvent have been computed on the basis of density functional theory by applying the gauge-including atomic orbital method.19

Results and discussion

Synthesis of hybrid ligands

We decided to prepare a series of new hybrid catalysts using the reaction of aldehyde derivatives of phenanthroline, bipyridyl and pyridine with enantiopure primary amines based on the bicyclic skeletons. Alcohol exo-(1S,3R,4R,1′S)-111 was oxidized to aldehyde 7 under Swern conditions;12 further conversion to oxime and its reduction yielded amine 3 in 48% overall yield (Scheme 1).13 Its ring-expanded isomer was prepared from alcohol 1 as well. The already described8 direct nucleophilic substitution using a reaction with HN3 under Mitsunobu conditions resulted in the ring expansion and the corresponding azide (1S,4S,5R,1′S)-8 was obtained. It was reduced to amine 5 (81% overall yield, Scheme 1). Similar procedures were used for the preparation of amines 4 and 6 starting from alcohol endo-(1S,3S,4R,1′S)-2 (Scheme 2). All four amines 3–6 were reacted with 1,10-phenanthroline-2-carboxaldehyde to give isomeric imines: two 2-azanorbornyl derivatives 11 and 12 and two compounds based on the bridged azepane skeleton 13 and 14 (Scheme 3). For comparison, 2-pyridyl and 6-(2,2′-bipyridyl) derivatives (9 and 10, respectively) were also prepared from amine (1S,3R,4R,1′S)-3 (Scheme 3). All new hybrid ligands were fully characterized using 1H NMR, 13C NMR, IR and HRMS to confirm their identities.
image file: c6nj02251k-s1.tif
Scheme 1 Synthesis of amines 3 and 5.8,13

image file: c6nj02251k-s2.tif
Scheme 2 Synthesis of amines 4 and 6.

image file: c6nj02251k-s3.tif
Scheme 3 Synthesis of imines 9–14.

Zinc(II) coordination of hybrid ligands – spectroscopic studies

The coordination ability of the new hybrid ligands 9–11 and 14 was investigated using 1H NMR spectroscopy. A methanol-d4 solution of zinc acetate, zinc chloride or zinc trifluoromethane–sulfonate was added stepwise to the solution of compound 11 and the process was monitored using 1H NMR. The representative spectra obtained during titration with Zn(OAc)2 are shown in Fig. 3. Addition of 0.1 equivalent of this salt to the solution of ligand 11 resulted in the formation of a new species represented by a new set of 1H NMR resonances which were visible together with the spectral lines of the starting compound. The formed complex predominated after addition of 0.5 equivalent of zinc acetate (Fig. 3, Trace B). An identical spectrum was obtained when zinc chloride or zinc triflate was used as a metal source. A diverse behavior, however, was observed upon further addition of Zn(II) salt to the obtained intermediate. In the case of Zn(OAc)2, a stepwise disappearance of resonances of this complex was accompanied by the building up of a new set attributed to the final form, the only one present after the addition of 1 equivalent of Zn(II) salt. Similar changes were noted for ZnCl2 addition, though line broadening and the formation of a precipitate were observed. Interestingly, additional portions of Zn(OTf)2 did not cause any significant alteration of the spectrum shown in Trace B of Fig. 3. These observations can be accounted for by the formation of two types of zinc complexes during the titration of 11 with zinc acetate: [ZnL2]2+, in which two molecules of ligand 11 are coordinated to the zinc(II) cation, and [ZnLXn](2−n)+ (n = 1, 2), with one molecule of ligand 11 replaced by acetate(s) (Fig. 4). The first one is formed independently on the metal source. In the case of ZnCl2 titration, the final form is presumably polymeric. Only the dimeric complex [ZnL2]2+ is formed when Zn(OTf)2 is used since the weakly coordinating triflate ion is not able to replace the phenanthroline derivative in the coordination sphere.
image file: c6nj02251k-f3.tif
Fig. 3 500 MHz 1H NMR spectra of compound 11 (A) and its complexes formed upon addition of 0.5 equivalent (B) and 1 equivalent (C) of zinc acetate. The most characteristic changes in the positions of resonances are indicated by straight lines. All spectra were measured in methanol-d4 at 300 K.

image file: c6nj02251k-f4.tif
Fig. 4 Two forms of the Zn(II) complexes of ligand 11 observed during NMR experiments.

In all cases, the possible interconversion between the uncoordinated ligand, [ZnL2]2+ and [ZnLXn](2−n)+ complexes was slow on the NMR scale; each form produced a separate set of sharp 1H NMR signals and their positions remained constant in the appropriate range of zinc salt concentrations.

The complex containing the acetate ligand(s) can be converted into the [ZnL2]2+ form by the addition of compound 11 to the methanolic solution of [ZnLXn](2−n)+. Complex [ZnL2]2+ was found to be insoluble in chloroform. When ligand 11 and zinc acetate were mixed in methanol in a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio and evaporated to dryness followed by dissolution of the residue in chloroform-d, the 1H NMR spectrum showed the presence of equimolar amounts of [ZnLXn](2−n)+ and the uncomplexed ligand. When we mixed compound 11 and zinc triflate in methanol in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio, the residue obtained after solvent removal was insoluble in chloroform-d, and the 1H NMR spectrum measured in methanol-d4 revealed the presence of the [ZnL2]2+ complex, in agreement with previous observations that for the OTf anion a monomeric complex was not formed.

Further information about the structures of the zinc(II) complexes comes from the analysis of the NMR chemical shifts. A complete assignment of the 1H and 13C NMR signals was based on correlations observed in the two-dimensional spectra (1H–1H COSY, 1H–13C HMQC, 1H–13C HMBC) and is given in Table S1 (ESI). The most characteristic shift changes are indicated by the straight lines in Fig. 3 and are listed in Table 1. The differences in resonance positions of complex [ZnLXn](2−n)+ and ligand 11 (Table 1, entry 4) can be attributed to the coordination of the metal ion. The data shown in Table 1 clearly demonstrate that the most pronounced changes upon the formation of the Zn(II) complexes are observed for the phenanthroline fragment and for protons 1′′ and 3′′ which indicates the engagement of aromatic amine and imine nitrogen atoms in the binding of the metal ion. In contrast, the chemical shifts of the 2-azanorbornane fragment and its 2-substituent remain practically unaffected suggesting that the tertiary amine is not involved in coordination. Two five-membered chelate rings are thus formed, in analogy to the known complexes of phenanthroline ligands bearing the appropriately located imine, oxime or pyridine fragment.20 The coordination sphere of zinc(II) is presumably filled by acetate(s), although a separate 1H NMR methyl signal of the coordinated anion(s) could not be observed due to the exchange with the free CH3COO even at 200 K. A similar 1H NMR pattern was observed for the analogous cadmium(II) complex, obtained by the addition of 1 equivalent of Cd(II) acetate to the ethanolic solution of ligand 11 (Fig. S9, ESI). The differences in the chemical shifts can be attributed to the bigger size of the Cd2+ ion and the presence of ethanol.

Table 1 Chosen 1H NMR chemical shifts of ligand 11 and its zinc complexes (methanol-d4, 300 K; L = ligand 11, X = OAc). The numbering scheme for ligand 11 is shown. Entries 4 and 5 show the chemical shift changes (see the text for details)

image file: c6nj02251k-u1.tif

Entry Species 1 3 4 5 1′′ 3′′ P3 P4 P8 P9
1 Ligand 11 3.72 2.49 2.31 1.38, 1.71 2.71, 3.11 8.27 8.23 8.42 7.79 9.10
2 [ZnL2]2+ 3.36 1.06 0.86 −1.46, 0.25 2.50, 3.04 8.84 8.88 9.45 7.63 7.63
3 [ZnLXn](2−n)+ 3.73 2.57 2.45 1.41, 1.69 2.89, 3.45 7.78 8.12 8.91 7.99 9.08
4 Difference 3-1 0.01 0.08 0.14 0.03, −0.02 0.18, 0.34 −0.49 −0.11 0.49 0.20 −0.02
5 Difference 2-3 −0.37 −1.51 −1.59 −2.87, −1.44 −0.39, −0.41 1.06 0.76 0.54 −0.36 −1.45


In contrast, significant 1H NMR shift changes were observed upon the formation of the [ZnL2]2+ complex. They can also be in part attributed to the coordination of the metal ion, but the most pronounced changes are connected with the mutual influence of the two ligand molecules. To estimate this effect, differences in the chemical shifts of [ZnL2]2+ and [ZnLXn](2−n)+ can be calculated (Table 1, entry 5). The aromatic ring current of the phenanthroline fragment causes upfield shifts of all protons of the 2-azanorbornane fragment of the second coordinated ligand. In particular, signals of 5-H protons found at 0.25 and −1.46 ppm can be regarded as a diagnostic feature of the formation of the [ZnL2]2+ complex. Significant upfield shifts were also observed for the fragments directly attached to the bicyclic skeleton (1′-H, 1′-Me, 1′′-H) and for the part of phenanthroline protons, while the location of the remaining protons of the aromatic amine and 3′′-H in the deshielding region resulted in their downfield chemical shifts.

Chemical shift changes caused by the coordination of the Zn2+ ion (for the [ZnLXn](2−n)+ and [ZnL2]2+ complexes) and aromatic ring current (for [ZnL2]2+) were also observed in the 13C NMR spectra (ESI, Table S2). They confirm the participation of the phenanthroline and imine nitrogen atoms in the formation of the metal complexes.

Zinc acetate titration of compound 14 containing the phenanthroline fragment attached to a ring-expanded skeleton resulted in 1H NMR spectral changes similar to those observed for the isomeric ligand 11. A stepwise formation of the [ZnL2]2+ and [ZnLXn](2−n)+ forms was found, and the general tendencies of the chemical shift changes resembled those described above for the 2-azanorbornane derivative. Also, the replacement of phenanthroline in compound 11 with 2,2′-bipyridyl did not cause qualitative differences in the ligand coordination modes, as it can be seen in Fig. 5 showing zinc acetate titration of derivative 10. Chemical shifts of the formed complexes are given in Tables S3 and S4 (ESI) along with the differences showing coordination-induced changes and changes caused by the ring current effect of the neighboring aromatic moieties. These values indicate zinc chelation by the three nitrogen atoms of bipyridyl and the appropriately located imine and the placement of the bicyclic fragment in the vicinity of the aromatic fragment of the second ligand in the [ZnL2]2+ complex.


image file: c6nj02251k-f5.tif
Fig. 5 500 MHz 1H NMR spectra of compound 10 (A) and its complexes formed upon addition of 0.5 equivalent (B) and 1 equivalent (C) of zinc acetate. The most pronounced changes in the positions of resonances are indicated by straight lines. All spectra were measured in methanol-d4 at 300 K.

In contrast, the removal of one of the pyridine subunits of 10 leads to a completely different picture. Addition of zinc acetate to the methanol-d4 solution of the 2-azanorbornane-based ligand containing 2-pyridyl substituent 9 resulted in the 1H NMR line broadening and, when a 2-fold excess of zinc salt was added to shift the equilibrium toward the formation of the product, a set of new signals attributed to the [ZnLXn](2−n)+ complex was observed (Fig. 6, trace B). Significant shift changes (in the range of 0.2–0.4 ppm) were observed for pyridine, 1′′ and 3′′ resonances suggesting that the pyridine and imine nitrogen atoms are engaged in coordination (ESI, Table S5). These two donors were found to be insufficient for the formation of the intermediate [ZnL2]2+-type complex observed previously for analogs 10 and 11.


image file: c6nj02251k-f6.tif
Fig. 6 Aromatic region of the 500 MHz 1H NMR spectra of compound 9 (A) and its complex formed upon the addition of 2 equivalents of zinc acetate (B). Both spectra were measured in methanol-d4 at 300 K.

The formation of the zinc complexes of phenanthroline derivative 11 was also followed using UV-vis spectroscopy. Addition of zinc acetate to the methanolic solution of ligand 11 resulted in a decrease of one of the two major bands at 277 nm and build-up of a band at ca. 295 nm accompanied by a less intense maxima at ca. 340 and 357 nm (Fig. 7A). Only very subtle differences were observed between the 2[thin space (1/6-em)]:[thin space (1/6-em)]1 and 1[thin space (1/6-em)]:[thin space (1/6-em)]1 complexes: the positions and intensities of all bands are almost identical (for the [ZnL2]2+ complex λmax (log[thin space (1/6-em)]ε) = 230 (4.55), 296 (4.31), 327 sh, 341 (3.65), 357 (3.52), for the [ZnL(OAc)n](2−n)+ form λmax (log[thin space (1/6-em)]ε) = 231 (4.54), 294 (4.32), 325 (3.71), 340 (3.68), 356 (3.62); for a better comparison, the values of log[thin space (1/6-em)]ε for the 2[thin space (1/6-em)]:[thin space (1/6-em)]1 complex were given per mole of the coordinated ligand). Not surprisingly, Job's plot (Fig. 6B) showing the changes in absorbance at 356 nm as a function of the mole fraction of zinc acetate exhibited a maximum for a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 ligand to Zn2+ ratio (x(Zn(OAc)2 = 0.33)). It is justified by the fact that for this composition the ligand is fully saturated with zinc and the concentration of the coordinated phenanthroline ligand (responsible for absorption) attains a maximum value.


image file: c6nj02251k-f7.tif
Fig. 7 (A) UV-vis spectra of ligand 11 and its zinc(II) complexes in methanolic solution. (B) Job's plot showing the absorbance at 356 nm as a function of the mole fraction of zinc acetate added to ligand 11.

DFT calculations

Quantum mechanical calculations performed at the DFT level of theory21 allowed comparison of possible structures and coordination modes for the obtained zinc complexes. In addition, chemical shifts in the 1H NMR spectra were calculated and compared with experimental values for the verification of the quality of theoretical predictions.

Calculations were performed for compounds 10 and 11 and their zinc complexes in methanolic solution. Using different starting points, we found two conformations of ligands 10 and 11 differing mainly in the relative positions of the two substituents of the bicyclic scaffold. The energy of the more compact one (Fig. 8A) appeared to be 3.74 kcal mol−1 (ligand 10) or 4.71 kcal mol−1 (ligand 11) higher than that for the open conformation (Fig. 8B). The calculated 1H NMR chemical shifts for the latter one were in a better agreement with the experimental values, particularly for the bicyclic fragment (ESI, Tables S7–S17, Fig. S10–S23). However, for the remaining parts of the molecule the conformational freedom does not allow us to expect a perfect fit.


image file: c6nj02251k-f8.tif
Fig. 8 DFT calculated structures of hybrid ligand 11. Two conformations of the molecule are shown with their relative energies. Hydrogen atoms are omitted for clarity.

For zinc complexes of a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometry, the calculations were performed for two modes of coordination. Structures in which ligand 10 or 11 coordinated to the metal ion using only two nitrogen atoms of the aromatic fragment were found to be significantly less stable (by 15–20 kcal mol−1, ESI, Table S6) than the complexes utilizing an imine donor as well. In addition, for this (3N) coordination the N-2 atom of 2-azanorbornane was also located at a binding distance of 2.12 Å from the zinc(II) cation. One should notice, however, that the competition of other possible ligands, in particular acetate anions, alcohol or water molecules, was not considered in these calculations. Our experiments indicated (3N) coordination and the presence of additional ligand(s) in the [ZnLXn](2−n)+ complexes. Therefore, calculations were also undertaken assuming additional coordination of one or two acetate anions. The agreement of the obtained NMR data with the experimental chemical shifts was not satisfactory which points toward another possible structure of the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 complex. One cannot exclude, for example, the formation of polynuclear species with bridging acetate anions. We performed several ESI MS experiments which showed the presence of either the [ZnL(OAc)]+ ion (m/z = 543.18) or the [ZnL–H]+ ion (m/z = 483.15) which can be formed under the experimental conditions from any mono- and polynuclear species. So far, we were not able to further characterize the isolated complex in the solid state (in particular, by using X-ray diffraction).

In the case of the complexes of a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 ligand to metal stoichiometry, [ZnL2]2+, DFT calculations were performed taking into account the possible coordination by only the phenanthroline or bipyridyl fragment, leading to tetrahedral geometry (4N-type complexes) and the possible engagement of the imine nitrogen atoms in the formation of the zinc complexes (6N-type octahedral structures). Again, the participation of the additional nitrogen donor in coordination resulted in more stable structures; the energy difference equalled 28.32 kcal mol−1 (for ligand 10) and 23.54 kcal mol−1 (ligand 11). In these structures shown in Fig. 9, bicyclic fragments are located in the vicinity of the aromatic fragments which should result in significant changes in the chemical shifts caused by the ring current effect.


image file: c6nj02251k-f9.tif
Fig. 9 DFT calculated structures of 6N-coordinated [ZnL2]2+ zinc(II) complexes with ligand 10 (A) and 11 (B). Hydrogen atoms are omitted for clarity.

DFT calculations of the 1H NMR chemical shifts reproduced well the experimental patterns observed for the [ZnL2]2+ complexes, including upfield shifts of 5-H in the complex of 11. The greatest deviations were observed for the N-2 substituent; possibly the averaged orientation of the phenyl moiety which has a pronounced effect on the chemical shifts of 1′-H and 1′-methyl protons differs for the calculated conformation. A representative illustration of the similarities in the calculated and measured values is presented in Fig. 10. All plots and tables showing the calculated chemical shifts are given in the ESI. While in the case of ligand 10 the differences between the calculated and experimental values are similar regardless of the coordination number, for ligand 11 much better correlation was found for 6N-type coordination compared to 4N-type coordination which is in agreement with our analysis of the NMR spectra.


image file: c6nj02251k-f10.tif
Fig. 10 Comparison of experimental and DFT calculated averaged chemical 1H NMR shift values (in ppm) of the 6N-coordinated [ZnL2]2+ complex of compound 11.

The main conclusions drawn from the DFT calculations are in agreement with those obtained from the NMR studies: participation of three nitrogen donors in metal ion binding which can leave vacant coordination sites in monomeric complexes, but not for the dimeric [ZnL2]2+ form. This implies the rational application of these complexes in asymmetric catalysis.

Stereoselective aldol reactions

Aldol reaction was chosen as a test process for checking the effect of the Zn(II) – containing hybrid catalysts on the outcome of the catalytic process.

We decided to test the newly synthesized enantiopure hybrid catalysts in the zinc-catalyzed aldol reaction between ketones and aromatic aldehydes. The results of the structural studies strongly suggested the use of [ZnLXn](2−n)+ complexes, where the metal coordination sphere offers enough space for additional coordination of the reacting species. Moreover, the reaction was performed in chloroform – a solvent in which the [ZnL2]2+ complex (with the ligands occupying 6 coordination sites) was found to be insoluble. Therefore, the reaction of cyclohexanone and 4-nitrobenzaldehyde with 10 mol% of catalyst (zinc acetate and 10–14 in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 molar ratio) was first tested (Table 2, entries 1–6).

Table 2 Results of stereoselective aldol reactionsa

image file: c6nj02251k-u2.tif

Entry Ligand L* Ar T (K) Additive Yield of product (%) dr

erb

a Reaction conditions:15 1 mL of chloroform, 1 mL of cyclohexanone, 0.5 mmol of aldehyde, 0.05 mmol of ligand, 0.05 mmol mol of zinc salt, and 0.05 mmol of acetic acid (entries 9, 16 and 17). b Configuration assignment based on the literature data.22 c 1% mol of both ligand and zinc acetate were used.
1 10 4-NO2-C6H4 298 Zn(OAc)2 85 syn/anti80[thin space (1/6-em)]:[thin space (1/6-em)]20

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 72[thin space (1/6-em)]:[thin space (1/6-em)]28, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 46[thin space (1/6-em)]:[thin space (1/6-em)]54

2 11 4-NO2-C6H4 298 Zn(OAc)2 92 syn/anti 60[thin space (1/6-em)]:[thin space (1/6-em)]40

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 51[thin space (1/6-em)]:[thin space (1/6-em)]49, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 53[thin space (1/6-em)]:[thin space (1/6-em)]47

3 11 4-NO2-C6H4 298 Zn(OAc)2 16 syn/anti 71[thin space (1/6-em)]:[thin space (1/6-em)]29

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 55[thin space (1/6-em)]:[thin space (1/6-em)]45, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 53[thin space (1/6-em)]:[thin space (1/6-em)]47

4 12 4-NO2-C6H4 298 Zn(OAc)2 95 syn/anti 70[thin space (1/6-em)]:[thin space (1/6-em)]30

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 50[thin space (1/6-em)]:[thin space (1/6-em)]50, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 48[thin space (1/6-em)]:[thin space (1/6-em)]52

5 13 4-NO2-C6H4 298 Zn(OAc)2 61 syn/anti 69[thin space (1/6-em)]:[thin space (1/6-em)]31

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 51[thin space (1/6-em)]:[thin space (1/6-em)]49, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 47[thin space (1/6-em)]:[thin space (1/6-em)]53

6 14 4-NO2-C6H4 298 Zn(OAc)2 84 syn/anti 57[thin space (1/6-em)]:[thin space (1/6-em)]43

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 50[thin space (1/6-em)]:[thin space (1/6-em)]50, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 50[thin space (1/6-em)]:[thin space (1/6-em)]50

7 10 4-NO2-C6H4 273 Zn(OAc)2 50 syn/anti83[thin space (1/6-em)]:[thin space (1/6-em)]17

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 45[thin space (1/6-em)]:[thin space (1/6-em)]55, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 52[thin space (1/6-em)]:[thin space (1/6-em)]48

8 11 4-NO2-C6H4 273 Zn(OAc)2 45 syn/anti74[thin space (1/6-em)]:[thin space (1/6-em)]26

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 62[thin space (1/6-em)]:[thin space (1/6-em)]38, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 55[thin space (1/6-em)]:[thin space (1/6-em)]45

9 11 4-NO2-C6H4 298 Zn(OAc)2 + HOAc 74 syn/anti 67[thin space (1/6-em)]:[thin space (1/6-em)]33

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 59[thin space (1/6-em)]:[thin space (1/6-em)]41, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 46[thin space (1/6-em)]:[thin space (1/6-em)]54

10 11 4-NO2-C6H4 298 ZnCl2 80 syn/anti 71[thin space (1/6-em)]:[thin space (1/6-em)]29

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 70[thin space (1/6-em)]:[thin space (1/6-em)]30, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 50[thin space (1/6-em)]:[thin space (1/6-em)]50

11 11 4-NO2-C6H4 298 Zn(OTf)2 70 syn/anti 40[thin space (1/6-em)]:[thin space (1/6-em)]60

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 51[thin space (1/6-em)]:[thin space (1/6-em)]49, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 70[thin space (1/6-em)]:[thin space (1/6-em)]30

12 11 4-NO2-C6H4 273 Zn(OTf)2 31 syn/anti 55[thin space (1/6-em)]:[thin space (1/6-em)]45

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 36[thin space (1/6-em)]:[thin space (1/6-em)]64, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 44[thin space (1/6-em)]:[thin space (1/6-em)]56

13 10 4-NO2-C6H4 273 Zn(OTf)2 >95 syn/anti 50[thin space (1/6-em)]:[thin space (1/6-em)]50

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 55[thin space (1/6-em)]:[thin space (1/6-em)]45, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 35[thin space (1/6-em)]:[thin space (1/6-em)]65

14 11 4-Cl-C6H4 273 Zn(OAc)2 10 syn/anti 59[thin space (1/6-em)]:[thin space (1/6-em)]41

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 93[thin space (1/6-em)]:[thin space (1/6-em)]7, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 74[thin space (1/6-em)]:[thin space (1/6-em)]26

15 11 4-Cl-C6H4 298 Zn(OAc)2 12 syn/anti74[thin space (1/6-em)]:[thin space (1/6-em)]26

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 91[thin space (1/6-em)]:[thin space (1/6-em)]9, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 53[thin space (1/6-em)]:[thin space (1/6-em)]47

16 11 4-Cl-C6H4 298 Zn(OAc)2 + HOAc 17 syn/anti >98[thin space (1/6-em)]:[thin space (1/6-em)]2

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) >99[thin space (1/6-em)]:[thin space (1/6-em)]1

17 14 4-Cl-C6H4 273 Zn(OTf)2 + HOAc 15 syn/anti82[thin space (1/6-em)]:[thin space (1/6-em)]18

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 94[thin space (1/6-em)]:[thin space (1/6-em)]6, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 41[thin space (1/6-em)]:[thin space (1/6-em)]59

18 11 2-NO2-C6H4 298 Zn(OAc)2 >95 syn/anti75[thin space (1/6-em)]:[thin space (1/6-em)]25

(2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 84[thin space (1/6-em)]:[thin space (1/6-em)]16, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 53[thin space (1/6-em)]:[thin space (1/6-em)]47



The highest diastereomeric ratio (80[thin space (1/6-em)]:[thin space (1/6-em)]20) with 42% enantiomeric excess of the main syn isomer accompanied by a 85% overall yield was obtained for bipyridyl ligand 10. Pyridine derivative 9 led to low diastereoselectivity (syn/anti 55[thin space (1/6-em)]:[thin space (1/6-em)]45, 65% yield) and racemic products, similarly to bridged azepane-based phenanthroline ligand 14. However, the use of the isomer of 14, 2-azanorbornyl derivative 11, resulted in a high yield but still low stereoselectivity. The decrease of the amount of catalyst from 10% to 1% drastically lowered the reaction yield, but slightly improved the dr and ee (entry 3). The yield dropped significantly, while the diastereomeric ratio increased with the decrease in reaction temperature (Table 2, entries 7–8).

Entries 9–13 show the impact of additives and metal sources on the outcome of the catalytic reaction. The addition of a Brønsted acid – acetic acid – slightly increased the stereoselectivity of the process (entries 9, 16, and 17). It can be accounted for in the protonation of the tertiary amine, thus additionally stabilizing the respective transition state via the hydrogen bond. The use of zinc triflate in place of zinc acetate with ligand 11 reversed the ratio of diastereomers and the major anti diastereomer was obtained with 40% ee. Furthermore, temperature lowering changed the stereochemical preference, suggesting that a specific mechanism operates for this catalyst composition.

When the reaction was performed with ligand 11 and zinc acetate was replaced with cadmium acetate, racemic products were obtained with low dr (syn/anti 52[thin space (1/6-em)]:[thin space (1/6-em)]48) in a 58% yield. Copper(II) acetate was only slightly more effective (82% yield, syn/anti 46[thin space (1/6-em)]:[thin space (1/6-em)]54, racemic products), while for copper(II) chloride the reaction exhibited some diastereo- and enantioselectivity (syn/anti 52[thin space (1/6-em)]:[thin space (1/6-em)]48; (2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 42[thin space (1/6-em)]:[thin space (1/6-em)]58, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 56[thin space (1/6-em)]:[thin space (1/6-em)]44), albeit accompanied by a lower yield (56%).

It is well established that the outcome of the aldol reaction can strongly depend on the solvent used.9d,22a In our hands, the results of the catalytic tests with ligand 11 and zinc acetate in methanol were found comparable with those in chloroform (88% yield, syn/anti 55[thin space (1/6-em)]:[thin space (1/6-em)]45, (2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 53[thin space (1/6-em)]:[thin space (1/6-em)]47, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 48[thin space (1/6-em)]:[thin space (1/6-em)]52). The reaction performed without solvent, with the addition of 5% mol of water, resulted in a reasonable yield (81%), but low diastereoselectivity (syn/anti 56[thin space (1/6-em)]:[thin space (1/6-em)]44) and a complete loss of enantioselectivity.

When 4-chlorobenzaldehyde was used as a substrate, low reaction yields (up to 17%) were observed. However, they were accompanied with high diastereoselectivities (up to over 98[thin space (1/6-em)]:[thin space (1/6-em)]2 dr) and enantioselectivities (82 to >98% ee for the major syn diastereomer; Table 2, entries 14–17). Promising results were also obtained when 4-nitrobenzaldehyde was reacted with cyclopentanone in the presence of 10 mol% of zinc acetate and 11 (syn[thin space (1/6-em)]:[thin space (1/6-em)]anti 55[thin space (1/6-em)]:[thin space (1/6-em)]45, (2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 70[thin space (1/6-em)]:[thin space (1/6-em)]30, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 35[thin space (1/6-em)]:[thin space (1/6-em)]65, >95% yield) and in the reaction of the same aldehyde with acetone (R[thin space (1/6-em)]:[thin space (1/6-em)]S 9[thin space (1/6-em)]:[thin space (1/6-em)]91, 58% yield).

As for ligands 11 and 14, we tested their utility as organocatalysts in the aldol reaction of cyclohexanone and 4-nitrobenzaldehyde. In both cases, similar yields (80/81%) and diastereomeric ratios (67[thin space (1/6-em)]:[thin space (1/6-em)]33) were noted, but only for the bridged azepane-based compound 14 were nonracemic products obtained ((2R,1′R)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′S) 55[thin space (1/6-em)]:[thin space (1/6-em)]45, (2R,1′S)[thin space (1/6-em)]:[thin space (1/6-em)](2S,1′R) 32[thin space (1/6-em)]:[thin space (1/6-em)]68).

The observed preference for the formation of an syn diastereomer can be explained by the favored formation of the Z-enolate in the transition state and placement of the aromatic substituent of the aldehyde in the less hindered region (Fig. 11).23


image file: c6nj02251k-f11.tif
Fig. 11 The plausible transition states for the aldol reaction catalyzed by a zinc complex of ligand 11. Adapted from the literature.23

The reversed diastereoselectivity for the catalysis with 11 and zinc triflate and its change with temperature may result from a simultaneous operation of diverse mechanisms: the reaction can be catalyzed by the ligand itself, which may also cooperate with the zinc salt present in the solution. Though we have not observed the formation of a monomeric zinc(II) complex of ligand 11 when Zn(OTf)2 was used as a metal source, the active species may be formed under the catalytic reaction conditions (chloroform/cyclohexanone solution).

Conclusions

New hybrid catalysts possessing a rigid chiral bicyclic skeleton with an additional tertiary amine and a 1,10-phenanthroline, 2,2′-bipyridine or pyridine moiety were obtained. The imine linkage provided an additional donor atom which participated in coordination. The Zn(II) complexation studies demonstrated that two types of complexes were formed, [ZnLXn](2−n)+ and [ZnL2]2+, and their structures were established by comparison of the experimental and DFT calculated NMR spectra. Actually, the first complex species formed with the chiral ligands were catalytically active in the zinc-catalyzed stereoselective aldol reaction. The preliminary results show that the outcome of the catalytic process is dependent on the configuration of the four stereogenic centers, the size of the bicyclic system as well as the linker size. Very high diastereomeric and enantiomeric excess of the main syn diastereomer were observed for the reaction of cyclohexanone and 4-chlorobenzaldehyde. The observed direction of stereochemical induction is in agreement with the generally accepted transition state structure for such a reaction. These promising results with the known versatility of phenanthroline, bipyridyl and pyridine derivatives substantiate a further exploration of the possible applications of these new bifunctional, chiral ligands in asymmetric catalysis.

Acknowledgements

Financial support from the National Science Center (grant OPUS-2013/09/B/ST5/03410) is gratefully acknowledged.

References

  1. (a) Multicatalyst System in Asymmetric Catalysis, ed. J. Zhou, John Wiley & Sons, Hoboken, NJ, 2015 Search PubMed; (b) L. H. Gade, Modular Assembly of Chiral Catalysts with Polydentate Stereodirecting Ligands, in Molecular Catalysts: Structure and Functional Design, ed. L. H. Gade and P. Hofmann, Wiley-VCH, Weinheim, 2014, pp. 313–342 Search PubMed.
  2. (a) G. Chelucci and R. P. Thummel, Chem. Rev., 2002, 102, 3129–3170 CrossRef CAS PubMed; (b) A. Bencini and V. Lippolis, Coord. Chem. Rev., 2010, 254, 2096–2180 CrossRef CAS; (c) A. V. Malkov, I. R. Baxendale, M. Bella, V. Langer, J. Fawcett, D. R. Russell, D. J. Mansfield, M. Valko and P. Kočovský, Organometallics, 2001, 20, 673–690 CrossRef CAS; (d) S. Kobayashi, T. Ogino, H. Shimizu, S. Ishikawa, T. Hamada and K. Manabe, Org. Lett., 2005, 7, 4729–4731 CrossRef CAS PubMed; (e) Y. Nishikawa and H. Yamamoto, J. Am. Chem. Soc., 2011, 133, 8432–8435 CrossRef CAS PubMed; (f) M. Liu, S. Ma, Z. Tian, H. Wu, L. Wu, X. Xu, Y. Huang and Y. Wang, Tetrahedron: Asymmetry, 2013, 24, 736–743 CrossRef CAS; (g) L. Zhang, H. Wu, Z. Yang, X. Xu, H. Zhao, Y. Huang and Y. Wang, Tetrahedron, 2013, 69, 10644–10652 CrossRef CAS; (h) M. Zielińska-Błajet, P. J. Boratyński, Ł. Sidorowicz and J. Skarżewski, Tetrahedron, 2016, 72, 2643–2648 CrossRef.
  3. Y. Naganawa, T. Namba, T. Aoyama, K. Shoji and H. Nishiyama, Chem. Commun., 2014, 50, 13224–13227 RSC.
  4. E. Wojaczyńska, J. Wojaczyński, K. Kleniewska, M. Dorsz and T. K. Olszewski, Org. Biomol. Chem., 2015, 13, 6116–6148 Search PubMed and references cited therein.
  5. (a) P. D. Bailey, R. D. Wilson and G. R. Brown, Tetrahedron Lett., 1989, 30, 6781–6784 CrossRef CAS; (b) H. Stella, H. Abraham, J. Feneau-Dupont, J. Tinant and J. P. Declercq, Tetrahedron Lett., 1990, 31, 2603–2606 CrossRef; (c) H. Waldmann and M. Braun, Liebigs Ann., 1991, 1045–1048 CrossRef CAS; (d) H. Nakano, N. Kumagai, C. Kabuto, H. Matsuzaki and H. Hongo, Tetrahedron: Asymmetry, 1995, 6, 1233–1236 CrossRef CAS.
  6. (a) J. K. Ekegren, S. A. Modin, D. A. Alonso and P. G. Andersson, Tetrahedron: Asymmetry, 2002, 13, 447–449 CrossRef CAS; (b) N. Hashimoto, H. Yasuda, M. Hayashi and Y. Tanabe, Org. Process Res. Dev., 2005, 9, 105–109 CrossRef CAS.
  7. P. Brandt and P. G. Andersson, Synlett, 2000, 1092–1106 CAS.
  8. E. Wojaczyńska, I. Turowska-Tyrk and J. Skarżewski, Tetrahedron, 2012, 68, 7848–7854 CrossRef.
  9. (a) Modern Methods in Stereoselective Aldol Reactions, ed. R. Mahrwald, Wiley-VCH, Weinheim, 2013 Search PubMed; (b) C. Palomo, M. Oiarbide and J. M. Garcia, Chem. Soc. Rev., 2004, 33, 65–75 RSC; (c) B. M. Trost and C. S. Brindle, Chem. Soc. Rev., 2010, 39, 1600–1632 RSC; (d) S. Itoh, S. Sonoike, M. Kitamura and S. Aoki, Int. J. Mol. Sci., 2014, 15, 2087–2118 CrossRef PubMed.
  10. (a) X.-F. Wu and H. Neumann, Adv. Synth. Catal., 2012, 354, 3141–3160 CrossRef CAS; (b) R. Vicente, Zinc-Catalyzed C–C Bond Formation, in Zinc Catalysis: Applications in Organic Synthesis, ed. S. Enthaler and X.-F. Wu, Wiley-VCH, Weinheim, 2015, pp. 119–177 Search PubMed.
  11. (a) H. Nakano, N. Kumagai, H. Matsuzaki, C. Kabuto and H. Hongo, Tetrahedron: Asymmetry, 1997, 8, 1391–1401 CrossRef CAS; (b) D. A. Alonso, D. Guijarro, P. Pinho, O. Temme and P. G. Andersson, J. Org. Chem., 1998, 63, 2749–2751 CrossRef CAS PubMed; (c) E. Wojaczyńska and J. Skarżewski, Tetrahedron: Asymmetry, 2008, 19, 2252–2257 CrossRef.
  12. (a) M. J. Södergren and P. G. Andersson, J. Am. Chem. Soc., 1998, 120, 10760–10761 CrossRef; (b) P. Brandt, C. Hedberg, K. Lawonn, P. Pinho and P. G. Andersson, Chem. – Eur. J., 1999, 5, 1692–1699 CrossRef CAS.
  13. K. Kamińska, E. Wojaczyńska, J. Wietrzyk, E. Turlej and A. Błażejczyk, Tetrahedron: Asymmetry, 2016, 27, 753–758 CrossRef.
  14. T. Norrby, A. Börje, L. Zhang and B. Åkermark, Acta Chem. Scand., 1998, 52, 77–85 CrossRef CAS.
  15. (a) G. Chen, X. Fu, C. Li, C. Wu and Q. Miao, J. Organomet. Chem., 2012, 702, 19–26 CrossRef CAS; (b) J. Paradowska, M. Pasternak, B. Gut, B. Gryzło and J. Młynarski, J. Org. Chem., 2012, 77, 173–187 CrossRef CAS PubMed.
  16. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N. J. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, Gaussian 09, Revision C.01, Gaussian, Inc., Wallingford CT, 2009 Search PubMed.
  17. Y. Zhao, N. E. Schultz and D. G. Truhlar, J. Chem. Phys., 2005, 123, 161103 CrossRef PubMed.
  18. J. Tomasi, B. Mennucci and R. Cammi, Chem. Rev., 2005, 105, 2999–3094 CrossRef CAS PubMed.
  19. J. R. Cheeseman, G. W. Trucks, T. A. Keith and M. J. Frisch, J. Chem. Phys., 1996, 104, 5497–5509 CrossRef CAS.
  20. (a) L. Wang, W.-H. Sun, L. Han, H. Yang, Y. Hu and X. Jin, J. Organomet. Chem., 2002, 658, 62–70 CrossRef CAS; (b) W.-H. Sun, S. Jie, S. Zhang, W. Zhang, Y. Song and H. Ma, Organometallics, 2006, 25, 666–677 CrossRef CAS; (c) J. R. Anacona and V. E. Marquez, Transition Met. Chem., 2008, 33, 579–583 CrossRef CAS; (d) J. R. Anacona, V. E. Marquez and J. Jimenez, J. Coord. Chem., 2009, 62, 1172–1179 CrossRef CAS; (e) A. Angeloff, J.-C. Daran, J. Bernadou and B. Meunier, Eur. J. Inorg. Chem., 2000, 1985–1996 CrossRef CAS; (f) A. N. Carolan, G. M. Cockrell, N. J. Williams, G. Zhang, D. G. VanDerveer, H.-S. Lee, R. P. Thummel and R. D. Hancock, Inorg. Chem., 2013, 52, 15–27 CrossRef CAS PubMed.
  21. (a) D. Sholl and J. A. Steckel, Density Functional Theory: A Practical Introduction, John Wiley & Sons, Hoboken, NJ, 2009 Search PubMed; (b) C. J. Cramer and D. G. Truhlar, Phys. Chem. Chem. Phys., 2009, 11, 10757–10816 RSC; (c) A. C. Tsipis, Coord. Chem. Rev., 2014, 272, 1–29 CrossRef CAS.
  22. (a) S. Itoh, T. Tokunaga, M. Kurihara and S. Aoki, Tetrahedron: Asymmetry, 2013, 24, 1583–1590 CrossRef CAS; (b) E. Machuca and E. Juaristi, Tetrahedron Lett., 2015, 56, 1144–1148 CrossRef CAS.
  23. H. E. Zimmerman and M. D. Traxler, J. Am. Chem. Soc., 1957, 79, 1920–1923 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available: Copies of NMR spectra, tables showing assignments of NMR signals of zinc complexes, DFT calculated energies, comparison of DFT calculated and experimental 1H NMR chemical shifts. See DOI: 10.1039/c6nj02251k

This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2016